Status:
COMPLETED
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
Lead Sponsor:
Fundação Educacional Serra dos Órgãos
Conditions:
Vertigo
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to assess the efficacy and safety of a combination of aminobutyric acid, glutamic acid, calcium, thiamine, pyridoxine and cyanocobalamin as adjuvant therapy for vert...
Detailed Description
Motion sickness is a chronic condition characterized by vestibular changes in response to stimuli caused either by movement or movement perception triggered by car, train, ship or aircraft transportat...
Eligibility Criteria
Inclusion
- clinical kinetosis
- female study subjects must agree in using contraceptives during study period
- dated informed consent read, understood and undersigned
Exclusion
- hypersensitivity to the drugs of the study
- history of gallblader stones
- history of gastric mucosa inflammation
- arterial blood pressure \>145/100 mmHg
- use of medication for kinetosis other than the study drugs
Key Trial Info
Start Date :
November 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT05221892
Start Date
November 22 2021
End Date
March 31 2023
Last Update
May 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Universitário Serra dos Órgãos - UNIFESO
Teresópolis, Rio de Janeiro, Brazil, 25964004